Graded transantral orbital decompression outcomes in stable thyroid eye disease: a series of 47 orbits.
Orbit, 2021/6;40(3):215-221.
Lu JE[1], Pfeiffer ML[1, 2], Burnstine MA[1, 2]
Affiliations
PMID: 32363975DOI: 10.1080/01676830.2020.1760313
Abstract
Purpose: To provide outcome data for transantral orbital decompression for functional and aesthetic rehabilitation for exophthalmos in stable thyroid eye disease (TED).Methods: Retrospective, non-comparative chart review of consecutive TED patients who underwent primary-graded transantral orbital decompression for exophthalmos by a single surgeon (MAB) between 2005 and 2018. Additional inclusion criteria included follow-up >90 days and no prior orbital surgery. Outcome data collection included millimeters of proptosis reduction, postoperative complications, and patient satisfaction.Results: A total 30 patients (47 orbits) were included. Average reduction in proptosis: 2.8 mm (range 0-9 mm, median 2.5 mm). Post-operatively, new onset diplopia occurred in four patients, V2 numbness in 15 patients (17 orbits), and sinusitis in 2 patients (2 orbits). Phone surveys reached 9/30 patients (14 orbits): cosmetic improvement was reported in 14/14 orbits, relief of orbital ache reported in 10/10 orbits with pre-operative ache, relief of dry eye in 8/13 orbits with preoperative dry eye, and overall satisfaction score: 8.9/10 (range 4-10, median 10).Conclusions: Graded transantral orbital decompression is a viable option for stable TED patients with orbital ache, exophthalmos, and exposure keratopathy, resulting in a high degree of functional and cosmetic satisfaction in our cohort.
Keywords: orbital decompression; thyroid eye disease; transantral orbital decompression
MeSH terms
Decompression, Surgical; Exophthalmos; Graves Ophthalmopathy; Humans; Orbit; Retrospective Studies; Treatment Outcome
More resources
EndNote: Download